{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:24:05Z","timestamp":1791473045762,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04042","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T10:12:16Z","timestamp":1392027136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predominant Role of Cytosolic Phospholipase A2\u03b1 in Dioxin-induced Neonatal Hydronephrosis in Mice"],"prefix":"10.1038","volume":"4","author":[{"given":"Wataru","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Aida-Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"key":"BFsrep04042_CR1","doi-asserted-by":"crossref","unstructured":"Fr\u00f8ki\u00e6r, J. & Zeidel, M. L. Urinary Tract Obstruction. in The Kidney (eds Taal, M. W. et al.) Ch. 37, 1383\u20131410 (Elsevier Saunders, 2011).","DOI":"10.1016\/B978-1-4160-6193-9.10037-5"},{"key":"BFsrep04042_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1542\/peds.2006-0120","volume":"118","author":"RS Lee","year":"2006","unstructured":"Lee, R. S., Cendron, M., Kinnamon, D. D. & Nguyen, H. T. Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics 118, 586\u2013593 (2006).","journal-title":"Pediatrics"},{"key":"BFsrep04042_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00467-012-2240-7","volume":"28","author":"KG Yamacake","year":"2013","unstructured":"Yamacake, K. G. & Nguyen, H. T. Current management of antenatal hydronephrosis. Pediatr Nephrol 28, 237\u2013243 (2013).","journal-title":"Pediatr Nephrol"},{"key":"BFsrep04042_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1464-4096.2001.woodward.2578.x","volume":"89","author":"M Woodward","year":"2002","unstructured":"Woodward, M. & Frank, D. Postnatal management of antenatal hydronephrosis. BJU Int 89, 149\u2013156 (2002).","journal-title":"BJU Int"},{"key":"BFsrep04042_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2131\/jts.34.519","volume":"34","author":"W Yoshioka","year":"2009","unstructured":"Yoshioka, W. et al. Severe toxicity and cyclooxygenase (COX)-2 mRNA increase by lithium in the neonatal mouse kidney. J Toxicol Sci 34, 519\u2013525 (2009).","journal-title":"J Toxicol Sci"},{"key":"BFsrep04042_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0031-6997(25)06814-0","volume":"46","author":"R Pohjanvirta","year":"1994","unstructured":"Pohjanvirta, R. & Tuomisto, J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms and animal models. Pharmacol Rev 46, 483\u2013549 (1994).","journal-title":"Pharmacol Rev"},{"key":"BFsrep04042_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.0959-9673.2005.00452.x","volume":"86","author":"G Molyneux","year":"2005","unstructured":"Molyneux, G. et al. The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse. Int J Exp Pathol 86, 415\u2013430 (2005).","journal-title":"Int J Exp Pathol"},{"key":"BFsrep04042_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1590\/S1677-55382004000600012","volume":"30","author":"A Goncalves","year":"2004","unstructured":"Goncalves, A., Franca, W. G., Moraes, S. G., Pereira, L. A. & Sbragia, L. Adriamycin-induced fetal hydronephrosis. Int Braz J Urol 30, 508\u2013513 (2004).","journal-title":"Int Braz J Urol"},{"key":"BFsrep04042_CR9","doi-asserted-by":"crossref","unstructured":"Schecter, A. & Gasiewicz, T. A. Dioxins and Health. 2 edn, (Wiley, 2003).","DOI":"10.1002\/0471722014"},{"key":"BFsrep04042_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tox.2006.07.020","volume":"227","author":"N Nishimura","year":"2006","unstructured":"Nishimura, N., Yonemoto, J., Nishimura, H. & Tohyama, C. Localization of cytochrome P450 1A1 in a specific region of hydronephrotic kidney of rat neonates lactationally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 227, 117\u2013126 (2006).","journal-title":"Toxicology"},{"key":"BFsrep04042_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1289\/ehp.730581","volume":"5","author":"JA Moore","year":"1973","unstructured":"Moore, J. A., Gupta, B. N., Zinkl, J. G. & Vos, J. G. Postnatal effects of maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Environ Health Perspect 5, 81\u201385 (1973).","journal-title":"Environ Health Perspect"},{"key":"BFsrep04042_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/0041-008X(71)90282-1","volume":"20","author":"KD Courtney","year":"1971","unstructured":"Courtney, K. D. & Moore, J. A. Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 20, 396\u2013403 (1971).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep04042_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.taap.2008.05.012","volume":"231","author":"N Nishimura","year":"2008","unstructured":"Nishimura, N. et al. Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxin. Toxicol Appl Pharmacol 231, 374\u2013383 (2008).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep04042_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0041-008X(91)90305-X","volume":"107","author":"L Couture-Haws","year":"1991","unstructured":"Couture-Haws, L., Harris, M. W., McDonald, M. M., Lockhart, A. C. & Birnbaum, L. S. Hydronephrosis in mice exposed to TCDD-contaminated breast milk: identification of the peak period of sensitivity and assessment of potential recovery. Toxicol Appl Pharmacol 107, 413\u2013428 (1991).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep04042_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0272-0590(90)90171-F","volume":"15","author":"LA Couture","year":"1990","unstructured":"Couture, L. A., Harris, M. W. & Birnbaum, L. S. Characterization of the peak period of sensitivity for the induction of hydronephrosis in C57BL\/6N mice following exposure to 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 15, 142\u2013150 (1990).","journal-title":"Fundam Appl Toxicol"},{"key":"BFsrep04042_CR16","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1073\/pnas.93.13.6731","volume":"93","author":"JV Schmidt","year":"1996","unstructured":"Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C. & Bradfield, C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A 93, 6731\u20136736 (1996).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep04042_CR17","first-page":"1194","volume":"26","author":"FJ Gonzalez","year":"1998","unstructured":"Gonzalez, F. J. & Fernandez-Salguero, P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 26, 1194\u20131198 (1998).","journal-title":"Drug Metab Dispos"},{"key":"BFsrep04042_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1365-2443.1997.1490345.x","volume":"2","author":"J Mimura","year":"1997","unstructured":"Mimura, J. et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645\u2013654 (1997).","journal-title":"Genes Cells"},{"key":"BFsrep04042_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsbmb.2010.12.005","volume":"127","author":"W Yoshioka","year":"2011","unstructured":"Yoshioka, W., Peterson, R. E. & Tohyama, C. Molecular targets that link dioxin exposure to toxicity phenotypes. J Steroid Biochem Mol Biol 127, 96\u2013101 (2011).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFsrep04042_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/toxsci\/kfs115","volume":"127","author":"W Yoshioka","year":"2012","unstructured":"Yoshioka, W. et al. Critical role of microsomal prostaglandin E synthase-1 in the hydronephrosis caused by lactational exposure to dioxin in mice. Toxicol Sci 127, 547\u2013554 (2012).","journal-title":"Toxicol Sci"},{"key":"BFsrep04042_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.plipres.2010.12.001","volume":"50","author":"M Murakami","year":"2011","unstructured":"Murakami, M. et al. Recent progress in phospholipase A research: from cells to animals to humans. Prog Lipid Res 50, 152\u2013192 (2011).","journal-title":"Prog Lipid Res"},{"key":"BFsrep04042_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jbiosc.2009.04.015","volume":"108","author":"M Kinehara","year":"2009","unstructured":"Kinehara, M., Fukuda, I., Yoshida, K. & Ashida, H. Aryl hydrocarbon receptor-mediated induction of the cytosolic phospholipase A(2)alpha gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse hepatoma Hepa-1c1c7 cells. J Biosci Bioeng 108, 277\u2013281 (2009).","journal-title":"J Biosci Bioeng"},{"key":"BFsrep04042_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1266\/ggs.83.455","volume":"83","author":"M Kinehara","year":"2008","unstructured":"Kinehara, M., Fukuda, I., Yoshida, K. & Ashida, H. High-throughput evaluation of aryl hydrocarbon receptor-binding sites selected via chromatin immunoprecipitation-based screening in Hepa-1c1c7 cells stimulated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Genes Genet Syst 83, 455\u2013468 (2008).","journal-title":"Genes Genet Syst"},{"key":"BFsrep04042_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bcp.2008.10.013","volume":"77","author":"F Matsumura","year":"2009","unstructured":"Matsumura, F. The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem Pharmacol 77, 608\u2013626 (2009).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep04042_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0304-4165(02)00485-3","volume":"1619","author":"J Mimura","year":"2003","unstructured":"Mimura, J. & Fujii-Kuriyama, Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619, 263\u2013268 (2003).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep04042_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1101\/gad.13.1.20","volume":"13","author":"J Mimura","year":"1999","unstructured":"Mimura, J., Ema, M., Sogawa, K. & Fujii-Kuriyama, Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13, 20\u201325 (1999).","journal-title":"Genes Dev"},{"key":"BFsrep04042_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1124\/jpet.107.132241","volume":"324","author":"IA Murray","year":"2008","unstructured":"Murray, I. A. & Perdew, G. H. Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J Pharmacol Exp Ther 324, 1102\u20131110 (2008).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep04042_CR28","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1073\/pnas.0511324103","volume":"103","author":"A Rojek","year":"2006","unstructured":"Rojek, A., Fuchtbauer, E. M., Kwon, T. H., Frokiaer, J. & Nielsen, S. Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A 103, 6037\u20136042 (2006).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep04042_CR29","doi-asserted-by":"publisher","first-page":"37871","DOI":"10.1074\/jbc.M205627200","volume":"277","author":"JN Lorenz","year":"2002","unstructured":"Lorenz, J. N. et al. Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome. J Biol Chem 277, 37871\u201337880 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep04042_CR30","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1073\/pnas.090091297","volume":"97","author":"N Takahashi","year":"2000","unstructured":"Takahashi, N. et al. Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc Natl Acad Sci U S A 97, 5434\u20135439 (2000).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep04042_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/37622","volume":"390","author":"N Uozumi","year":"1997","unstructured":"Uozumi, N. et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, 618\u2013622 (1997).","journal-title":"Nature"},{"key":"BFsrep04042_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bcp.2009.08.031","volume":"79","author":"B Dong","year":"2010","unstructured":"Dong, B., Nishimura, N., Vogel, C. F., Tohyama, C. & Matsumura, F. TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochem Pharmacol 79, 487\u2013497 (2010).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep04042_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.taap.2011.12.009","volume":"259","author":"P Bui","year":"2012","unstructured":"Bui, P., Solaimani, P., Wu, X. & Hankinson, O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol Appl Pharmacol 259, 143\u2013151 (2012).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep04042_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/toxsci\/62.1.103","volume":"62","author":"PL Bryant","year":"2001","unstructured":"Bryant, P. L., Schmid, J. E., Fenton, S. E., Buckalew, A. R. & Abbott, B. D. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and\/or TGF-alpha. Toxicol Sci 62, 103\u2013114 (2001).","journal-title":"Toxicol Sci"},{"key":"BFsrep04042_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/taap.1997.8173","volume":"145","author":"HM Theobald","year":"1997","unstructured":"Theobald, H. M. & Peterson, R. E. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-rho-dioxin: effects on development of the male and female reproductive system of the mouse. Toxicol Appl Pharmacol 145, 124\u2013135 (1997).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep04042_CR36","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen, S. & Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365\u2013386 (2000).","journal-title":"Methods Mol Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04042","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:31:46Z","timestamp":1746131506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04042"],"URL":"https:\/\/doi.org\/10.1038\/srep04042","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]},"assertion":[{"value":"24 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4042"}}